Cox regression analysis for baseline characteristics in NA-ACCORD (N = 717) and COMPLETE (N = 450)
| . | Multivariate analysis . | Univariate analysis . | ||
|---|---|---|---|---|
| Variable . | HR (95% CI) . | P . | HR (95% CI) . | P . |
| HIV infection* (yes, no) | 1.92 (1.27, 2.91) | .002 | 1.80 (1.25, 2.59) | .001 |
| Age (y) | 1.02 (1.01, 1.03) | <.001 | 1.01 (1.01, 1.02) | .002 |
| Female sex (yes, no)† | 1.00 (0.77, 1.30) | .98 | ||
| Race‡ | ||||
| Black (yes, no) | 1.65 (1.19, 2.29) | .002 | 1.72 (1.26, 2.35) | <.001 |
| Other | 1.75 (1.11, 2.77) | .02 | 1.60 (1.02, 2.52) | .04 |
| CKD§ (yes, no) | 1.35 (0.74, 2.47) | .33 | ||
| HBVǁ (yes, no) | 2.10 (1.04, 4.25) | .04 | ||
| HCVǁ (yes, no) | 1.90 (1.06, 3.39) | .03 | ||
| ATLL (yes, no) | 1.45 (0.75, 2.83) | .27 | ||
| ALCL (yes, no) | 0.55 (0.37, 0.80) | .002 | 0.59 (0.42, 0.84) | .004 |
| AITL (yes, no) | 1.12 (0.80, 1.56) | .52 | ||
| CTCL (yes, no) | 1.19 (0.74, 1.89) | .48 | ||
| NK/TCL (yes, no) | 0.89 (0.58, 1.36) | .59 | ||
| PTCL-NOS (yes, no) | 1.35 (1.04, 1.74) | .02 | ||
| . | Multivariate analysis . | Univariate analysis . | ||
|---|---|---|---|---|
| Variable . | HR (95% CI) . | P . | HR (95% CI) . | P . |
| HIV infection* (yes, no) | 1.92 (1.27, 2.91) | .002 | 1.80 (1.25, 2.59) | .001 |
| Age (y) | 1.02 (1.01, 1.03) | <.001 | 1.01 (1.01, 1.02) | .002 |
| Female sex (yes, no)† | 1.00 (0.77, 1.30) | .98 | ||
| Race‡ | ||||
| Black (yes, no) | 1.65 (1.19, 2.29) | .002 | 1.72 (1.26, 2.35) | <.001 |
| Other | 1.75 (1.11, 2.77) | .02 | 1.60 (1.02, 2.52) | .04 |
| CKD§ (yes, no) | 1.35 (0.74, 2.47) | .33 | ||
| HBVǁ (yes, no) | 2.10 (1.04, 4.25) | .04 | ||
| HCVǁ (yes, no) | 1.90 (1.06, 3.39) | .03 | ||
| ATLL (yes, no) | 1.45 (0.75, 2.83) | .27 | ||
| ALCL (yes, no) | 0.55 (0.37, 0.80) | .002 | 0.59 (0.42, 0.84) | .004 |
| AITL (yes, no) | 1.12 (0.80, 1.56) | .52 | ||
| CTCL (yes, no) | 1.19 (0.74, 1.89) | .48 | ||
| NK/TCL (yes, no) | 0.89 (0.58, 1.36) | .59 | ||
| PTCL-NOS (yes, no) | 1.35 (1.04, 1.74) | .02 | ||
Reference group: non-HIV.
Reference group: male.
Reference group: White.
Patients with CKD were defined as those who ever had an eGFR consistently <60 mL/min per 1.73 m2 for at least 3 months.
HBV, hepatitis B virus, as determined by detection of surface antigen, e antigen, or DNA quantification; HCV, hepatitis C virus as determined by detection of antibody, RNA quantification, or genotype.